Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4534_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
27 Мб
Скачать
7 Immune Responses toRespiratory Infections
93
promoting the stimulation of CD8+ T-cell responses. Some CD4+ T cells exhibit cytolytic activity mediated by perforin after inuenza infection [11]. The CD8+ T cells recognize and eliminate virus-infected cells through mechanisms mediated by perforins and granzymes or apoptosis. Furthermore, virus-specic CD8+ T cells are capable of generating both anti-inammatory interleukin (IL)-10 and pro-inam­matory mediators such as tumor necrosis factor (TNF) and IFN-γ, thereby maintain­ing the balance with effective antiviral responses [11, 28]. It is observed that, following the clearance of the virus, these two pro-inammatory mediators are reduced. For IL-10 to be produced in lung tissues, IL-27 (released by mononuclear cells and neutrophils) and IL-2 (produced by T CD4+ lymphocytes) are required [27]. As well as CD4+ and CD8+ T lymphocytes and regulatory T cells (Tregs) are involved in immune response modulation. A large number of regulatory interleukins are produced by these cells, such as IL-10 and transforming growth factor-β1 (TGF­β1) and inhibitory molecules such as CTLA-4 (cytotoxic T-lymphocyte-associated protein) [27]. Following clearance, part of the effector T cells converts into circulat­ing and tissue-resident memory T cells, providing long-term immunity against re­infection, while others undergo apoptosis during the contraction phase [29].
Bacterial infections sometimes occur as superinfection following viral infec­tions. In this situation, macrophages usually represent the rst line of defense. These macrophages are also responsible for recruiting and activating other immune cells and controlling the spread of bacterial infections. Inammatory response to extra­cellular bacteria, such as S. pneumoniae, is primarily driven by neutrophil inltra­tion and secondarily by a late adaptive immunity regulated by Th1 and Th17 cells. Additionally, the production of specic antibodies against the microorganisms is provided by B lymphocytes [27]. Of note, IgM, IgG, and IgA are fundamental in the response against bacteria, and particularly capsulated bacteria, as shown by the recurrence of S. pneumoniae and H. inuenzae infections in patients with primary antibody deciencies (PAD), often leading to airway remodeling and bronchiectasis [30]. Notably, the evaluation of the antibody response to vaccination is part of the diagnostic process of common variable immunodeciency. In these patients with a suspicion of PAD, the assessment of the response to pneumococcal polysaccharide vaccines is used as a gold standard to assess T-independent antibody responses [31]. In particular, between IgG subclasses, IgG2 plays a prominent role as an anti­polysaccharide antibody. Also, specic antibody deciencies are reported, in which a specic inability to mount an antibody response against puried Streptococcus pneumoniae capsular polysaccharide antigens is detected. This may occur despite normal total IgG, IgA, and IgM levels and preserved antibody responses to protein antigens [32].
Fungi are ubiquitous indoor and outdoor microorganisms that will likely increase in prevalence and antigenicity with global climate change. Fungi contain cell wall molecules such as β-glucan and chitin and secrete biologically active proteases and glycosidases. Innate immune cells, such as airway epithelial cells and dendritic cells, are equipped with cell surface molecules that respond to these fungal prod­ucts, leading to the production of cytokines and proinammatory mediators. As a
94
E. Topyildiz et al.
result, protection against fungal infection is enhanced by generating the adaptive arm of antifungal immunity, including Th1, Th2, and Th17-type CD4+ T cells [33].
In conclusion, immune responses to respiratory infections are complex processes involving both innate and adaptive components. The immune system’s ability to recognize, neutralize, and eliminate pathogens is a remarkable defense mechanism that helps maintain respiratory health. The clinical picture of patients affected by IEI clearly recapitulates the importance of the different branches of the immune system in the response against respiratory pathogens and helps in understanding the mechanisms [34]. The knowledge of these responses is crucial to the development of effective therapies and preventive strategies for a wide variety of respiratory infections.

References

1. Baroody FM, Naclerio RM.Immunology of the upper airway and pathophysiology and treat­ment of allergic rhinitis. In: Flint PW, Haughey BH, Lund VJ, etal., editors. Cummings oto­laryngology: head and neck surgery, vol. 1. 5th ed. St. Louis, MO: Mobsy; 2010. p.597–623.
2. Jeffrey Modell Foundation. Primary immunodeciency resource centre. http://www.info4pi.
org/library/educational- materials/10- warning- signs. Accessed 7 Mar 2017.
3. GBD 2015 LRI Collaborators. Estimates of the global, regional, and national morbidity, mor­tality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analy­sis for the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017;17(11):1133–61.
https://doi.org/10.1016/S1473- 3099(17)30396- 1.
4. Govers C, Calder PC, Savelkoul HFJ, Albers R, van Neerven RJJ.Ingestion, immunity, and infection: nutrition and viral respiratory tract infections. Front Immunol. 2022;13:841532. Published 2022 Feb 28. https://doi.org/10.3389/mmu.2022.841532.
5. Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010;363(23):2233–47. https://doi.org/10.1056/NEJMra0910061.
6. Ioannidis I, Ye F, McNally B, Willette M, Flaño E.Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells. J Virol. 2013;87(6):3261–70.
https://doi.org/10.1128/JVI.01956- 12.
7. Tengroth L, Millrud CR, Kvarnhammar AM, Kumlien Georén S, Latif L, Cardell LO.Functional effects of Toll-like receptor (TLR)3, 7, 9, RIG-I and MDA-5 stimulation in nasal epithelial cells. PLoS One. 2014;9(6):e98239. Published 2014 Jun 2. https://doi.org/10.1371/journal.
pone.0098239.
8. Kotenko SV, Durbin JE. Contribution of type III interferons to antiviral immunity: loca­tion, location, location. J Biol Chem. 2017;292(18):7295–303. https://doi.org/10.1074/jbc.
R117.777102.
9. Zola TA, Lysenko ES, Weiser JN. Mucosal clearance of capsule-expressing bacteria requires both TLR and nucleotide-binding oligomerization domain 1 signaling. J Immunol. 2008;181(11):7909–16. https://doi.org/10.4049/jimmunol.181.11.7909.
10. Picard C, Puel A, Bustamante J, Ku CL, Casanova JL.Primary immunodeciencies associated with pneumococcal disease. Curr Opin Allergy Clin Immunol. 2003;3(6):451–9. https://doi.
org/10.1097/00130832- 200312000- 00006.
11. Wei X, Narasimhan H, Zhu B, Sun J.Host recovery from respiratory viral infection. Annu Rev Immunol. 2023;41:277–300. https://doi.org/10.1146/annurev- immunol- 101921- 040450.
12. Lee AJ, Chen B, Chew MV, etal. Inammatory monocytes require type I interferon recep­tor signaling to activate NK cells via IL-18 during a mucosal viral infection. J Exp Med. 2017;214(4):1153–67. https://doi.org/10.1084/jem.20160880.
13. Aldridge JR Jr, Moseley CE, Boltz DA, etal. TNF/iNOS-producing dendritic cells are the nec­essary evil of lethal inuenza virus infection. Proc Natl Acad Sci USA. 2009;106(13):5306–11.
https://doi.org/10.1073/pnas.0900655106.
7 Immune Responses toRespiratory Infections
14. Hikono H, Kohlmeier JE, Ely KH, etal. T-cell memory and recall responses to respiratory virus infections. Immunol Rev. 2006;211:119–32. https://doi.org/10.1111/j.0105- 2896.2006.
00385.x.
15. Eisenbarth SC.Dendritic cell subsets in T cell programming: location dictates function. Nat Rev Immunol. 2019;19(2):89–103. https://doi.org/10.1038/s41577- 018- 0088- 1.
16. Smit JJ, Rudd BD, Lukacs NW.Plasmacytoid dendritic cells inhibit pulmonary immunopa­thology and promote clearance of respiratory syncytial virus. J Exp Med. 2006;203(5):1153–9.
https://doi.org/10.1084/jem.20052359.
17. GeurtsvanKessel CH, Willart MA, van Rijt LS, etal. Clearance of inuenza virus from the lung depends on migratory langerin+CD11b but not plasmacytoid dendritic cells. J Exp Med. 2008;205(7):1621–34. https://doi.org/10.1084/jem.20071365.
18. Bastard P, Zhang Q, Zhang SY, Jouanguy E, Casanova JL.Type I interferons and SARS-CoV-2: from cells to organisms. Curr Opin Immunol. 2022;74:172–82. https://doi.org/10.1016/j.
coi.2022.01.003.
19. Bi J.NK cell dysfunction in patients with COVID-19. Cell Mol Immunol. 2022;19(2):127–9.
https://doi.org/10.1038/s41423- 021- 00825- 2.
20. Lujan RA, Vrba SM, Hickman HD.Antiviral activities of group I innate lymphoid cells. J Mol Biol. 2022;434(6):167266. https://doi.org/10.1016/j.jmb.2021.167266.
21. Juno JA, Keynan Y, Fowke KR.Invariant NKT cells: regulation and function during viral infection. PLoS Pathog. 2012;8(8):e1002838. https://doi.org/10.1371/journal.ppat.1002838.
22. Diana J, Lehuen A. NKT cells: friend or foe during viral infections? Eur J Immunol. 2009;39(12):3283–91. https://doi.org/10.1002/eji.200939800.
23. Ho LP, Denney L, Luhn K, Teoh D, Clelland C, McMichael AJ.Activation of invariant NKT cells enhances the innate immune response and improves the disease course in inuenza A virus infection. Eur J Immunol. 2008;38(7):1913–22. https://doi.org/10.1002/eji.200738017.
24. Gil E, Noursadeghi M, Brown JS. Streptococcus pneumoniae interactions with the comple­ment system. Front Cell Infect Microbiol. 2022;12:929483. Published 2022 Jul 28. https://doi.
org/10.3389/fcimb.2022.929483.
25. Skattum L, van Deuren M, van der Poll T, Truedsson L. Complement deciency states and associated infections. Mol Immunol. 2011;48(14):1643–55. https://doi.org/10.1016/j.
molimm.2011.05.001.
26. Stambas J, Lu C, Tripp RA.Innate and adaptive immune responses in respiratory virus infec­tion: implications for the clinic. Expert Rev Respir Med. 2020;14(11):1141–7. https://doi.
org/10.1080/17476348.2020.1807945.
27. Borzutzky Schachter A, Morales Matamala P. Immunological defense mechanisms of the respiratory system. In: Bertrand P, Sánchez I, editors. Pediatric respiratory diseases. Cham: Springer; 2020. https://doi.org/10.1007/978- 3- 030- 26961- 6_6.
28. Hua L, Yao S, Pham D, et al. Cytokine-dependent induction of CD4+ T cells with cyto­toxic potential during inuenza virus infection. J Virol. 2013;87(21):11884–93. https://doi.
org/10.1128/JVI.01461- 13.
29. Sun J, Madan R, Karp CL, Braciale TJ. Effector T cells control lung inammation during acute inuenza virus infection by producing IL-10. Nat Med. 2009;15(3):277–84. https://doi.
org/10.1038/nm.1929.
30. Durandy A, Kracker S, Fischer A. Primary antibody deciencies. Nat Rev Immunol. 2013;13(7):519–33. https://doi.org/10.1038/nri3466.
31. Bonilla FA.Vaccines in patients with primary immune deciency. Immunol Allergy Clin N Am. 2020;40(3):421–35. https://doi.org/10.1016/j.iac.2020.03.004.
32. Sorensen RU, Edgar D. Specic antibody deciencies in clinical practice. J Allergy Clin Immunol Pract. 2019;7(3):801–8. https://doi.org/10.1016/j.jaip.2019.01.024.
33. Bartemes KR, Kita H.Innate and adaptive immune responses to fungi in the airway. J Allergy Clin Immunol. 2018;142(2):353–63. https://doi.org/10.1016/j.jaci.2018.06.015.
34. Conti F, Marzollo A, Moratti M, Lodi L, Ricci S.Inborn errors of immunity underlying a sus­ceptibility to pyogenic infections: from innate immune system deciency to complex pheno­types. Clin Microbiol Infect. 2022;28(11):1422–8. https://doi.org/10.1016/j.cmi.2022.05.022.
95

Respiratory Microbiome

ÜlküRabiaKorkmaz, OmerFarukCetiner, AshaRani, RaviRanjan, andAyşeBilgeÖztürk

8.1 Introduction

The human body hosts a complex community of microorganisms called “microbi­ota,” the number of which is 10 times more than the total human cell count [1]. Microbial species belonging to this heterogeneous community exhibit different dynamics according to time and place [2]. They are affected by the environment and are in active communication both with the host and among themselves [2].
Human microbiota, which has become increasingly popular in the last 20years, has now begun to be dened as our “last organ” [1]. As only less than 1% of the bacteria can be cultured in the laboratory [3], therefore, bacterial laboratory culture is no longer the gold standard for understanding the role of microbiota in greater detail. Today, genetic molecular analysis of polymorphic bacterial 16SrRNA gene sequencing is considered the main method to characterize microbiota [2, 3]. Since
8
Ü. R. Korkmaz Institute of Asthma and Allergy Prevention, Helmholtz Zenter Munich, Neuherberg, Germany e-mail: ulku-rabia.korkmaz@helmholtz-munich.de
O. F. Cetiner Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
A. Rani Department of Food Science, University of Massachusetts Amherst, Amherst, MA, USA e-mail: arani@umass.edu
R. Ranjan Genomics Resource Laboratory, Institute for Applied Life Sciences, University of Massachusetts Amherst, Amherst, MA, USA e-mail: ranjan@umass.edu
A. B. Öztürk (*) Department of Allergy and Immunology, Medeniyet University Faculty of Medicine, Istanbul, Turkey
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2024 H. Yüksel et al. (eds.), Pediatric Airway Diseases, Comprehensive ENT,
https://doi.org/10.1007/978-3-031-74853-0_8
97
98
Ü. R. Korkmaz et al.
the beginning of the 2000s, gene sequencing technology with high data output has been widely used, and its routine use in the elds of proteomics, metabolomics, and epigenomics has led to the historical microbiology term “microbiota” [2]. This rapid technological development has also led to promising options in the prevention of diseases and personalized medicine [3].
The entire gene summation of all microbes (bacteria, bacteriophage, fungi, pro­tozoa, and viruses) belonging to the microbiota of a specic environment is termed the “microbiome” [3]. The “Human Microbiome Project-HMP” is one of the most comprehensive international projects which has led to over 200 scientic studies in the literature. The HMP project was planned as an open data portal in 2007 [4] and this project dened the normal microbiomes of the nasal, oral, skin, gastrointestinal tract, and urogenital regions of healthy people.
When “The Human Microbiome Project-HMP” was planned, human airways were not sampled because the lungs were thought to be sterile, but the role of airway microbiota in disease and health is now well established [5]. Since its discovery, the role of the respiratory microbiome in the pathogenesis of various lung diseases has been investigated. A growing body of scientic data from observational clinical studies and laboratory studies supports the role of microbiota in the pathogenesis of airway disease and healthy lungs [5]. Our microbiota may play a key modulatory role in immune, metabolic, and cellular functions, activating disease-related inam­matory signals, increasing airway disease susceptibility and disease severity, as well as directing different phenotypes [3, 6].
Airways are directly exposed to allergens, microbes, and other irritants, and inhaled air contains 104–106 bacterial cells/m3 [7]. Lung microbiota occurs by the balance of microbial immigration, microbial elimination, and the relative reproduc­tion rates of its members [3]. Temperature, pH, oxygen tension, nutrient availability, local microbial competition, host epithelial cell interactions, activation of inam­matory cells, and concentration of inammatory cells all have an effect on the microbiota [3]. The healthy lung has a diverse microbiota and the most prevalent phyla in the airways are Bacteroidetes and Firmicutes. Streptococcaceae (Firmicutes), Veillonellaceae (Firmicutes), Prevotellaceae (Bacteroidetes), Fusobacteriaceae (Fusobacteria), Neisseriaceae (Betaproteobacteria), Porphyromonadaceae (Bacteroidetes), and Lachnospiraceae (Firmicutes) are the most prevalent bacteria found in healthy lung airways [3].
Although it is well known that the intestinal microbiota has a critical importance for human physiology, the “lung microbiota” of healthy individuals has been a less studied subject. Lung microbiota has long been accepted as sterile, and routine sam­pling encounters various difculties. Despite its low density and reduced bacterial load, lung microbiota plays a primary role in maintaining a balance between the immune system and epithelial responses [3]. Local and distant effects of the bacte­rial load of the lung have a decisive effect on many respiratory diseases, including asthma [3, 6, 8].
Although the results of childhood asthma studies have been highly variable because of the different methods used to assess bacterial populations, however, there are extensive data available on childhood asthma and microbiota. This
8 Respiratory Microbiome
99
chapter aims to summarize the current literature on airway microbiota, with a focus on childhood asthma studies, to provide a comprehensive approach to the respiratory microbiome and its relationship with airway disease. Accumulating evidence indicates that the airway microbiome may provide valuable predictive insights for the diagnosis of asthma, a basis for identifying risk factors and potential targets for treatment options [6]. In this review, we provide the most essential concepts and recent developments related to the airway microbiome in the context of pediatric asthma. This review also highlights the noteworthy stud­ies that have contributed signicantly to advancing our understanding of airway microbiomes.
8.2 Childhood Asthma andRespiratory Microbiome
8.2.1 Childhood Asthma
Childhood asthma, the most prevalent disease of childhood, is identiable by its phenotype characterized by initial recurrent wheezing, followed by the occurrence of airway obstruction and narrowing within the initial 6 years of life [9, 10]. Approximately 3–5% of individuals develop persistent wheeze symptoms from childhood into adulthood [11]. The subsequent existence of numerous proinam­matory cells, such as mast cells, eosinophils, T-lymphocytes, macrophages, or neu­trophils, leads to bronchial constriction, mucosal edema, and increased mucus production [12]. Although in older children and adults the prevalence of asthma is associated with serum IgE level, asthma development is independent of the IgE level at birth [13]. While there has been signicant advancement in comprehending the pathogenic mechanisms (risk and protective factors, phenotypes, triggers, etc.) and distinctions between children and adults in asthma, our understanding of effec­tive prevention strategies remains incomplete.
Microbial colonization starts in utero, and it is inuenced by many factors, including maternal microbiome, infection, the season of birth, mode of birth, pet exposure, breastfeeding, farming, the existence of older siblings, and use of antibi­otics in early life [1417]. A delicate balance is maintained by microbes, which could be benecial or harmful. During early life, chronic microbial (viral, bacterial, and fungal) infection or colonization by microbial agents in the lower airway could result in impaired mucociliary clearance that stimulates an increase in mucus pro­duction and ultimately contributes to the development of asthma [18, 19].
Newborns born in summer exhibited higher bacterial richness and specic pro­les, with an increased abundance of Gram-negative α-proteobacteria and Gram­positive Bacilli in their nasopharynx at 1 month, contrasting with those born in other seasons, suggesting that birth season inuences the early colonization of specic pathogens in the upper airways [20]. Another study highlighted peak colonization periods for M. catarrhalis in fall/winter and for H. inuenzae in winter/spring, reecting regular cycles of colonization and clearance in healthy children. The observed rise in M. catarrhalis and H. inuenzae detection during winter is likely
100
Ü. R. Korkmaz et al.
attributed to an uptick in viral respiratory infections, such as inuenza, creating more opportunities for secondary infections by bacterial pathogens [21].
Interestingly, infants who have experienced respiratory illnesses accompanied by wheezing in their rst year tend to exhibit lower lung function levels even before the onset of any lower respiratory diseases than infants without wheezing-related ill­ness [22, 23]. This suggests that respiratory infections are associated with childhood asthma and may also impact the development and severity of asthma [24]. However, the crucial factor in shaping host immune responses lies in the nature, type, and tim­ing of exposure to microbes [25, 26]. While viral infections appear to play a signi­cant role in initiating wheezing and respiratory distress in early life, exposure to specic bacterial species may have a protective effect [23].
On the other hand, epidemiological studies have indicated that living in a micro­bial-rich environment in early life protects against developing asthma, particularly in children exposed to farming [2731]. Recent data on farming indicate that DNA from mattress dust consists of Clostridium and Facklamia species which were posi- tively associated with farming [32]. Whether the inhalation of metabolites of envi­ronmental bacteria contributes to this strong inverse association of asthma with bacterial diversity is not clearly understood [32]. Another outstanding study from Depner etal. revealed that the presence of asthma was positively correlated with a particular operational taxonomic unit from the genus Moraxella in children without exposure to farming. However, in children from farming environments, Moraxella colonization showed no association with asthma [32]. von Mutius etal. identied 84 farming and nonfarming families in rural regions of Southern Germany and Switzerland. This study suggested that the degree of environmental exposure to endotoxins and other bacterial wall components plays a signicant role as a protec­tive determinant in preventing the onset of atopic diseases during childhood [33]. Furthermore, the meta-analyses show that the protective “farm effect” is stronger than what individuals brought up in inner cities can experience by exposure to pets, daycare, and siblings.
8.2.2 Asthma Exacerbation
Asthma exacerbations represent a signicant factor contributing to morbidity and, in severe cases, mortality of children affected by asthma [34]. Various factors can contribute to asthma exacerbation, including infections, underuse of asthma control medications, or exposure to allergens or pollutants. Although asthma exacerbations may occur at any time during the year, seasonal factors play a crucial role in child­hood asthma. This is particularly prevalent during autumn and spring in temperate climates when viral respiratory tract infections are most widespread [34]. Viral infections play a pivotal role, contributing signicantly to as many as 90% of exac­erbations [35]. On the other hand, summer exacerbations were associated with com­promised pulmonary function, sensitivity to Alternaria spp., elevated blood eosinophil counts, increased doses of inhaled corticosteroids (ICS), and a history of exacerbation in the preceding season [35].
8 Respiratory Microbiome
101

8.3 Bacteriome

In 2010, the rst distinctive microbiome analysis from bronchoscopy was obtained using 16S rRNA gene marker sequencing technology in eight healthy individuals [36]. Interestingly, the identied bacteria in the lower airways were found to be distinct from those in the upper respiratory tract [36]. The bacteria associated with lower chronic respiratory conditions might be colonized commensally in the upper and lower respiratory tracts of healthy individuals [37]. While it is not well dened whether the upper or lower microbiome is more relevant for asthma occurrence, the bacterial burden in the upper airway is greater than the lower airway. The inamma­tory condition in the local airway impacts the lower airway health using postnasal drip or aspiration, resulting in the downward translocation of pathogens [38, 39]. Colonization of the respiratory tract with bacterial pathogens triggers cell recruit­ment and inammation in the airways via enhancing inammatory response to allergens [40].
A study conducted in the Copenhagen Childhood Birth Cohort, involving 321 neonates monitored over their rst 5 years of life, aimed to explore the potential relationship between bacterial colonization of the hypopharynx in asymptomatic neonates and the development of asthma [19]. The ndings indicated that coloniza­tion with Streptococcus pneumoniae, Haemophilus inuenzae, and Moraxella catarrhalis in the airway or a combination were at greater risk for recurrent wheeze and exacerbation, as well as asthma development via an increase in blood eosino­phil and serum IgE levels [19, 41]. Subsequent follow-up studies indicated that these bacteria are associated with asthma exacerbations [42]. Similarly, a prospec­tive cohort study of 234 children with acute respiratory infections revealed that colonization with Streptococcus in the nasopharynx (NP) during the critical rst year of life is linked to childhood asthma development [42]. Additionally, the Finish Birth Cohort Study (STEPS) made signicant progress in understanding the nasal airway microbiome by identifying ve different microbiota proles in 923 infants at the age of 2, including Moraxella-dominant, Streptococcus-dominant, Dolosigranulum-dominant, Staphylococcus-dominant, and Corynebacteriaceae­dominant proles [43, 44]. Among these microbiotas, Moraxella species were asso­ciated with a greater risk of respiratory diseases later in childhood [44].
A Childhood Asthma birth cohort study involving infants in the rst 2years of life indicated that the nasopharyngeal Staphylococcus-dominant microbiome in the rst 6months of life was associated with an increased risk of recurrent wheezing by age 3years and asthma that persisted throughout childhood [45]. Moreover, this path was linked with early allergen sensitization. Furthermore, in cases of wheez­ing, the identication of the prevalence of Moraxella was correlated with the persis­tence of asthma into later childhood [45]. Upon subsequent follow-up of the same cohort, the frequency of both upper and lower respiratory tract infections was linked to asthma development by the age of 7 [46].
Another study focusing on nasal microbiome highlighted the association of pedi­atric asthma with Proteobacteria and Moraxella [47]. A study involving nasal blow samples from 214 children highlighted that airway microbiota colonization is
102
Ü. R. Korkmaz et al.
differentially associated with the risk of loss of asthma control and severe exacerba­tion [48]. Specically, airway microbiota dominated by the Corynebacterium and Dolosigranulum cluster was associated with a lower risk of asthma compared to microbiota dominated by more pathogenic bacteria such as Staphylococcus,
Streptococcus, and Moraxella [45]. Likewise, a study highlighted that Moraxella catarrhalis, an opportunistic human respiratory pathogen, has been identied as a
dominant species of nasal airway microbiotas of children (age range 6–17years) who experience a greater frequency of exacerbation [49]. Furthermore, invitro nd­ings demonstrate that strains from Moraxella catarrhalis may cause epithelial dam­age and elevate the expression of IL-8 and IL-33 [44]. Microbial taxonomic analysis from Chile revealed that the nasal mucosa was dominated by a high abundance of
Moraxella, Dolosigranulum, Haemophilus, Corynebacterium, Streptococcus, and Staphylococcus, whereas the oral mucosa was characterized by a high abundance of Streptococcus, Haemophilus, Gemella, Veillonella, Neisseria, and Porphyromonas
in asthmatic children [50]. Kim etal. demonstrated in a cross-sectional case–control study an elevated proportion of Firmicutes in upper airway samples among indi­viduals with asthma compared to control as well as children with asthma remission [51]. In addition, atypical bacteria such as Mycoplasma pneumoniae and Chlamydophila pneumoniae, recognized as common respiratory pathogens, have been linked to asthma, wheezing, and asthma exacerbations in children [5254].
Unlike the upper respiratory microbiota, there are only a few studies that have reported the potential association between the lower airway microbiota and asthma [36, 5557]. Hilty etal. collected samples of lower airways from children with and without asthma [36]. Microbiome analysis indicated that children with asthma are richer in Firmicutes phyla and Haemophilus genus [36]. The use of a mouse model of Haemophilus infection demonstrated that corticosteroid treatment, the main treatment to reduce airway inammation in people with asthma, promotes Haemophilus inuenzae persistence, which suggests that this bacterium may respond directly to corticosteroid via inuencing biolm formation [58]. In line, Ovaalbumin (OVA)-induced Haemophilus inuenzae-infected mouse shows that a combination of infection and allergic airway disease promotes bacterial persistence, leading to the development of steroid-resistant neutrophilic asthma [59] via immune modulation [60]. Moreover, bronchoalveolar lavage (BAL) pellets from children who underwent bronchoscopy over 20months with severe asthma showed signi­cantly enriched abundance of Bacteroides, Faecalibacterium, Roseburia, Ruminococcus, Parabacteroides, Romboutsia, Alistipes, Eubacterium, and other ve bacteria in comparison to control, whereas Proteus and Capnocytophaga showed higher abundance in samples from individuals without severe asthma com­pared to those with the condition [57].
While association with bacteria and its potential risk for asthma development is already multifarious, an additional layer of complexity might be added by potential interaction between viruses and bacteria to shape host microbiome relationships by altering mucosal surfaces. Following virus infection, cells may decrease the anti­bacterial peptides and induce bacterial colonization and replication both directly and indirectly via the upregulation of adherence receptors [61]. The nested cohort
8 Respiratory Microbiome
103
of 118 with conrmed respiratory syncytial virus (RSV), which is one of the most common causes of upper and lower acute respiratory infections (ARIs), indicated that higher nasopharyngeal detection and abundance of Lactobacillus during infancy were consistently associated with a reduced risk of subsequent wheezing illnesses at age 2 [62].
Evidence has shown that the microbiome is associated with asthma pathogene­sis, but how microbiota and their metabolites shape immune pathways to drive asthma is still not fully understood. Depending on bacterial species, immune modu­lation alters. While Proteobacteria species provoke T helper (Th) 17 inammation, which is associated with noneosinophilic asthma, some Acinetobacter species are associated with Th2/eosinophilic asthma [63]. Bronchoalveolar lavage from chil­dren aged from 4 to 32months with wheezing has demonstrated that an increase in the alveolar macrophages and neutrophil, but not of eosinophil and mast cells, sug­gests an association between bacterial colonization and initiating event of allergic asthma [64].

8.4 Virome

Viral infections have been repeatedly and consistently associated with wheezing [6567]. Various evidence indicates that viral infections exacerbate asthma [6870]. Among the plethora of respiratory viruses, in particular, rhinovirus (RV) stands out as the predominant single trigger for exacerbations, accounting for as much as 76% of wheezing episodes in children [67, 7173]. In addition, early-life rhinovirus wheezing illnesses and aeroallergen sensitization are the most potent risk factors for asthma at school age [74]. Rhinoviruses (RVs) can induce a range of illnesses, span­ning from asymptomatic infections to severe conditions affecting the lower respira­tory tract [75]. RV also regulates airway hyperresponsiveness, a key characteristic feature of asthma [76]. The Copenhagen prospective study on asthma childhood (COPSAC) has identied RV as a pathogen inducing severe respiratory disease potential [42, 77]. Data have highlighted that RV-induced bronchiolitis was more strongly associated with the risk of developing wheeze and childhood asthma [73]. Notably, RV as a cause of rst-time wheezing in children using corticosteroid treat­ment could be effective. Clinical trials indicate that children who got a short dose of oral corticosteroids not only wheezed less in the following year [78, 79] but also had a 30% lower risk of developing asthma over the next 4–7years [79, 80].
Children prone to developing asthma may have a tendency to create an inam­matory environment favoring Th2 responses, along with a connection to specic risk genes like CDHR3 [71]. Factors like weakened interferon responses, a compro­mised airway barrier, environmental exposures (like an imbalanced airway microbi­ome), and nutritional deciencies (low vitamin D and sh oil) increase the risk of infections from viruses, including RV [71]. Whether viral illnesses actually cause asthma is still a topic of active debate.
Another prevalent respiratory virus, respiratory syncytial virus (RSV), is among the most significant risk factors for the onset of wheezing in infants and